EC Healthcare Further Issue Shares to Strategic Shareholder Dr. Cheng Chi Kong and Aspex Management To Enhance Collaboration in Deploying Medical Real Estate Strategy
HONG KONG, Jul 9, 2021 - (ACN Newswire via SEAPRWire.com) - EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong, announces that the Group's strategic shareholders Dr. Cheng Chi Kong and Aspex Management further increase equity stake in the Group via Top-up Placing, further enhancing the strategic relationship and empowering the Group's development. The Group conditionally agreed to effectively issue and allot 6,455,172 and 10,758,621 new Shares at HK$14.50 per Share to Dr. Cheng Chi Kong, Adrian JP and Aspex Master Fund (the "Purchasers"), respectively, through Top-up Placing. Such shares representing approximately 1.55% of the issued share capital of the Company and approximately 1.53% of its enlarged issued share capital immediately following the Top-up Placing. The Group expects to receive net proceeds of approximately HK$248.8 million from the transaction and intends to use the proceeds for clinic network expansion in Hong Kong and the Greater Bay Area in the PRC, mergers and acquisitions and general corporate purposes. Haitong International Securities Compa...
